{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:27:02Z","timestamp":1789885622959,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.coviro.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T15:15:15Z","timestamp":1492096515000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches"],"prefix":"10.1016","volume":"23","author":[{"given":"Nisreen MA","family":"Okba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V Stalin","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L","family":"Haagmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2017.03.007_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.immunol.25.022106.141706","article-title":"The Immunobiology of SARS*","volume":"25","author":"Chen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.coviro.2017.03.007_bib0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","article-title":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation","volume":"14","author":"Haagmans","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0020","doi-asserted-by":"crossref","first-page":"e00884","DOI":"10.1128\/mBio.00884-14","article-title":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia","volume":"5","author":"Alagaili","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2017.03.007_bib0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1473-3099(13)70164-6","article-title":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study","volume":"13","author":"Reusken","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0030","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3201\/eid2108.150481","article-title":"Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013\u20132014","volume":"21","author":"Reusken","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1473-3099(15)70090-3","article-title":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study","volume":"15","author":"Muller","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrp.2015.08.006","article-title":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015","volume":"6","author":"Korea Centers for Disease Control and Prevention","year":"2015","journal-title":"Osong Public Health Res. Perspect."},{"key":"10.1016\/j.coviro.2017.03.007_bib0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12916-015-0450-0","article-title":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study","volume":"13","author":"Chowell","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.coviro.2017.03.007_bib0050","doi-asserted-by":"crossref","first-page":"9081","DOI":"10.1073\/pnas.1519235113","article-title":"Unraveling the drivers of MERS-CoV transmission","volume":"113","author":"Cauchemez","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.coviro.2017.03.007_bib0055","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid2211.160920","article-title":"Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel","volume":"22","author":"Alraddadi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0060","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJMoa1405858","article-title":"Transmission of MERS-coronavirus in household contacts","volume":"371","author":"Drosten","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.coviro.2017.03.007_bib0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","article-title":"Animal models of Middle East respiratory syndrome coronavirus infection","volume":"122","author":"van Doremalen","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.coviro.2017.03.007_bib0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0300985815620845","article-title":"A comparative review of animal models of Middle East respiratory syndrome coronavirus infection","volume":"53","author":"Baseler","year":"2016","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2016.01.004","article-title":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3\/2012","volume":"490","author":"Johnson","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2017.03.007_bib0085","doi-asserted-by":"crossref","first-page":"31629","DOI":"10.1038\/srep31629","article-title":"Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.coviro.2017.03.007_bib0090","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/infdis\/jiw080","article-title":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection","volume":"213","author":"Houser","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0095","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.coviro.2017.03.007_bib0100","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1128\/JVI.00446-15","article-title":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection","volume":"89","author":"Zhao","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0105","doi-asserted-by":"crossref","first-page":"326ra321","DOI":"10.1126\/scitranslmed.aaf1061","article-title":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo","volume":"8","author":"Luke","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.coviro.2017.03.007_bib0110","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.coviro.2017.03.007_bib0115","first-page":"477","article-title":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection","volume":"62","author":"Corman","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0120","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea","volume":"21","author":"Park","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0125","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/JCM.01368-15","article-title":"Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia","volume":"53","author":"Muth","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0130","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.coviro.2017.03.007_sbref0135","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2017.03.007_bib0140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.coviro.2017.03.007_bib0145","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0150","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0155","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0160","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0165","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3201\/eid2210.160706","article-title":"Persistence of antibodies against Middle East respiratory syndrome coronavirus","volume":"22","author":"Payne","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1473-3099(13)70304-9","article-title":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility","volume":"14","author":"Cauchemez","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0175","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3201\/eid2111.151231","article-title":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015","volume":"21","author":"Majumder","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0180","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3201\/eid2111.150764","article-title":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014","volume":"21","author":"Feikin","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2017.03.007_bib0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000366162","article-title":"Vaccines for the elderly","volume":"61","author":"Del Giudice","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.coviro.2017.03.007_bib0195","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2353\/ajpath.2008.071060","article-title":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice","volume":"172","author":"Nagata","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0200","doi-asserted-by":"crossref","first-page":"e1000756","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.coviro.2017.03.007_bib0205","doi-asserted-by":"crossref","first-page":"e1000636","DOI":"10.1371\/journal.ppat.1000636","article-title":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice","volume":"5","author":"Zhao","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.coviro.2017.03.007_bib0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JVI.01805-10","article-title":"Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus","volume":"85","author":"Sheahan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_sbref0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","article-title":"T cell-mediated immune response to respiratory coronaviruses","volume":"59","author":"Channappanavar","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.coviro.2017.03.007_bib0220","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1172\/JCI59777","article-title":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice","volume":"121","author":"Zhao","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.coviro.2017.03.007_bib0225","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1084\/jem.20150632","article-title":"Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection","volume":"212","author":"Vijay","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.coviro.2017.03.007_bib0230","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans","volume":"3","author":"van Boheemen","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2017.03.007_bib0235","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jit609","article-title":"Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses","volume":"209","author":"Agnihothram","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0240","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"Mou","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0245","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","article-title":"Immunization with inactivated Middle East respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus","volume":"12","author":"Agrawal","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.coviro.2017.03.007_bib0250","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0255","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_sbref0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coviro.2017.03.007_bib0265","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus","volume":"145","author":"Guo","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.coviro.2017.03.007_bib0275","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01815-15","article-title":"A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform","volume":"89","author":"Malczyk","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0280","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02040-16","article-title":"One-health: a safe, efficient, dual-use vaccine for humans and animals against Middle East respiratory syndrome coronavirus and rabies virus","volume":"91","author":"Wirblich","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0285","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1038\/nmicrobiol.2016.226","article-title":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome","volume":"2","author":"Cockrell","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2017.03.007_bib0290","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.coviro.2017.03.007_bib0295","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.coviro.2017.03.007_bib0300","article-title":"MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.coviro.2017.03.007_bib0305","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/vim.2014.0080","article-title":"The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents","volume":"27","author":"Yang","year":"2014","journal-title":"Viral Immunol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vaccine.2016.11.064","article-title":"The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection","volume":"35","author":"Jiaming","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0320","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against middle east respiratory syndrome coronavirus challenge","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0325","doi-asserted-by":"crossref","first-page":"e112602","DOI":"10.1371\/journal.pone.0112602","article-title":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen","volume":"9","author":"Lan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2017.03.007_bib0330","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1016\/j.vaccine.2014.08.086","article-title":"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments\u2014the importance of immunofocusing in subunit vaccine design","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0335","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0340","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/21645515.2015.1021527","article-title":"Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus","volume":"11","author":"Tang","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.coviro.2017.03.007_bib0345","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.virol.2016.10.005","article-title":"A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection","volume":"499","author":"Tai","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2017.03.007_bib0350","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2014.02.004","article-title":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.03.007_bib0355","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciu812","article-title":"An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014","volume":"60","author":"Drosten","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.coviro.2017.03.007_bib0360","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1128\/JVI.02232-14","article-title":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness","volume":"88","author":"Sui","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0365","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Dec 16 (1)","key":"10.1016\/j.coviro.2017.03.007_bib0370","article-title":"Recombinant receptor-binding domains of multiple MERS-coronaviruses induce cross-neutralizing antibodies against divergent human and camel MERS-coronaviruses and antibody-escape mutants","volume":"91","author":"Tai","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.coviro.2017.03.007_bib0375","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jinf.2013.03.015","article-title":"Cross-reactive antibodies in convalescent SARS patients\u2019 sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests","volume":"67","author":"Chan","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.coviro.2017.03.007_sbref0380","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/ncomms13473","article-title":"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.coviro.2017.03.007_bib0385","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol. J."},{"issue":"Suppl 2","key":"10.1016\/j.coviro.2017.03.007_bib0390","first-page":"31","article-title":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement","volume":"18","author":"Jaume","year":"2012","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.coviro.2017.03.007_bib0395","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.coviro.2017.03.007_bib0400","doi-asserted-by":"crossref","unstructured":"Vaccine initiative marks bold resolution. Nature 2017, 541:436.","DOI":"10.1038\/541436a"},{"key":"10.1016\/j.coviro.2017.03.007_bib0405","doi-asserted-by":"crossref","first-page":"e00650","DOI":"10.1128\/mBio.00650-13","article-title":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate","volume":"4","author":"Almazan","year":"2013","journal-title":"MBio"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T14:50:42Z","timestamp":1535899842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716301481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":81,"alternative-id":["S1879625716301481"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2017.03.007","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}